NeuroFlow Stock
NeuroFlow is a HIPAA compliant digital health platform that optimizes the way behavioral healthcare is delivered, tracked, and assessed.
Sign up today and learn more about NeuroFlow Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About NeuroFlow Stock
NeuroFlow is a platform to be a resource and asset to healthcare providers in their pursuit to get patients better and improve lives. It is a cloud-based platform that empowers healthcare providers to track, assess, and engage patients using evidence-based practices to support their mental health. The suite of tools supports remote monitoring and behavioral health integration across the continuum of care, including psychology, primary care, and pain management settings, to increase patient engagement and improve compliance.
Investors
Magellan Health Services
Funding History
| October 2017 | $1.3M |
|---|---|
| July 2018 | $225K |
| September 2018 | $2.3M |
| December 2019 | $7.5M |
| April 2020 | $749K |
| January 2021 | $20.0M |
| September 2022 | $750K |
| October 2022 | $25.0M |
Management
CEO & Co-Founder
Christopher Molaro
COO & Co-Founder
Adam Pardes
Director & Health Plan Sales
David Santivasci
VP of Sales
Neal Smart
Chief Product Officer
Julia Kastner
Advisory Board Member
Carl Buhler
Member Board Of Directors
Mark McAdoo
Press
fiercehealthcare - Apr, 5 2024
'Podnosis': A closer look at the impact of measurement-based care in behavioral healthhitconsultant - Feb, 10 2024
Concord Health Invests in NeuroFlow's Behavioral Health SaaS Platform6abc - Jan, 24 2024
Network teaches veterans to climb the business laddertechnical - Dec, 20 2023
Philly's NeuroFlow expands its Veterans Affairs reach with the ...prnewswire - Dec, 20 2023
Concord Health Partners Invests in NeuroFlowEquityZen Recognized As:
